Honesty•Accuracy

Professionalism•Responsibility

Honesty•Accuracy

Professionalism•Responsibility

Honesty•Accuracy•Professionalism•Responsibility

Core Value

About
MDG

Medgaea Life Sciences is a third party laboratory that is certificated for OECD GLP, TFDA GLP, ISO 17025 and ISO 9001. Maily based on preclinical CRO, we provide total-soltion services to assist biotechnology industries successfully obtain the product certification and exploit internation market.

CRO

Needs Discuss
Quote and Ordar
Timetable Schedule
Report Launch
Case Closed

Services

With devoting to our core value 『Honesty•Accuracy•Professionalism•Responsibility』,

We have successfully assisted our customers to successfully obtain the product certification in FDA, CE, TFDA and NMPA.

Medical Devices

One of the first priority of medical devices R&D is their safety. The Biocompatibility test is mainly followed the ISO 10993 international standard.

Cell therapy and Regenerative medicine

We assist the safety, effectiveness tests during the R&D process of cell therapy product. All the tests are complied with GLP.

Pharmaceutical development

As the agent of SNBL in Taiwan, will help new drugs company to complete non-clinical trials in medium, large animals and primates in the research and development stage.

Agrochemical and Enviromental Agents

The agroculture products need to review their toxicological data in advance, and all the tests must be carried out in complies with GLP.

Chemical Substances

Providing the toxicological test information!
EPA acquired the test information as the core basis to evaluate the substance announcement.

Health Food/ Ingredients

Provide safety, efficacy and stability tests for food ingredients and health foods.

Registration

Provide registration services.

Pharmaceuticals

Provide batch examine for medicine release, including pyrogen, acute systemic toxicity and other tests.

Laboratory animals and Equipment

An agent and supplier based on research and development of animal experiments, providing import services for various disease model animals in research institutions.

麥德凱生科20週年：從CRO到CIO，打造台灣生技國際合作平台

【台北訊】創立於2005年的麥德凱生科股份有限公司（MDG），於2025年迎來20週年，正式宣示，從「CRO（Contract Research Organization）」轉型為「CIO（Collaborative Innovation Organization）」，開啟以創新協作為核心的全新發展階段。

此次於BIO Asia–Taiwan 2025（展位N1009）重磅登場，展示其在毒理學試驗、GLP合規驗證、生物相容性評估、食品安全及功效性評估與法規輔導等一站式服務，並攜手SNBL、JFRL、CBT及Biocytogen等國際級實驗夥伴，展現卓越的跨國整合能力。

MDG在過去20年間持續耕耘於藥品、醫療器材與健康食品領域，協助客戶通過美國FDA、歐盟EU、日本FFC等國際申請規範。面對全球實驗動物使用逐步受限，MDG積極導入3R原則（Replacement, Reduction, Refinement），並領先業界整合AI人工智慧與大數據分析系統，發展替代性試驗策略與高通量毒理風險預測模型，以加速試驗流程並提升結果再現性。

展望未來十年，MDG將以CIO定位，攜手更多台灣品牌從早期開發到全球法規申請，提供策略性研發路徑諮詢與全方位試驗設計支援，協助台灣生技企業有效銜接國際市場規格，結合產業、學術、醫療與研究機構的資源，打造全方位創新合作模式。

搜尋關鍵字：#麥德凱生科 #CRO #CIO #毒理試驗 #GLP報告 #3R原則 #AI毒理分析 #前臨床試驗 #台灣生技 #國際法規